UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Psoriasis associated with anti‐tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature

Alimentary pharmacology & therapeutics, 2011-12, Vol.34 (11‐12), p.1318-1327

2011

Volltextzugriff (PDF)

The Crohn's disease activity index (CDAI) is similarly elevated in patients with Crohn's disease and in patients with irritable bowel syndrome

Alimentary pharmacology & therapeutics, 2013-04, Vol.37 (8), p.786-794

2013

Volltextzugriff (PDF)

Meta‐analysis: targeting the intestinal microbiota in prophylaxis for post‐operative Crohn’s disease

Alimentary pharmacology & therapeutics, 2010-04, Vol.31 (8), p.802-809

2010

Volltextzugriff (PDF)

Outcomes after escalation of infliximab therapy in ambulatory patients with moderately active ulcerative colitis

Alimentary pharmacology & therapeutics, 2012-03, Vol.35 (5), p.562-567

2012

Volltextzugriff (PDF)

Systematic review: the quality of the scientific evidence and conflicts of interest in international inflammatory bowel disease practice guidelines

Alimentary pharmacology & therapeutics, 2013-05, Vol.37 (10), p.937-946

2013

Volltextzugriff (PDF)

Infliximab trough concentrations during maintenance therapy are associated with endoscopic and histologic healing in ulcerative colitis

Alimentary pharmacology & therapeutics, 2018-02, Vol.47 (4), p.478-484

2018

Volltextzugriff (PDF)

The use of pharmacological prophylaxis against venous thromboembolism in hospitalised patients with severe active ulcerative colitis

Alimentary pharmacology & therapeutics, 2014-05, Vol.39 (9), p.940-948

2014

Volltextzugriff (PDF)

Letter: infliximab concentrations during induction therapy—one size does not fit all

Alimentary pharmacology & therapeutics, 2018-05, Vol.47 (9), p.1334-1335

2018

Volltextzugriff (PDF)

Editorial: early post‐induction anti‐TNF drug monitoring can predict long‐term therapeutic outcomes in inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2018-02, Vol.47 (3), p.436-437

2018

Volltextzugriff (PDF)

Editorial: therapeutic de‐escalation of anti‐tumour necrosis factor therapy – is less enough?

Alimentary pharmacology & therapeutics, 2017-05, Vol.45 (9), p.1265-1266

2017

Volltextzugriff (PDF)

The impact of infliximab infusion reactions on long‐term outcomes in patients with Crohn’s disease

Alimentary pharmacology & therapeutics, 2008-07, Vol.28 (2), p.221-227

2008

Volltextzugriff (PDF)

Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.913-921

2018

Volltextzugriff (PDF)

Commentary: irritable bowel syndrome and the CDAI – misleading activity by straw men; authors’ reply

Alimentary pharmacology & therapeutics, 2013-05, Vol.37 (10), p.1021-1022

2013

Volltextzugriff (PDF)

Letter: inflammatory bowel disease guidelines and conflicts of interest – authors' reply

Alimentary pharmacology & therapeutics, 2013-08, Vol.38 (4), p.445-446

2013

Volltextzugriff (PDF)

Letter: international IBD practice guidelines – authors’ reply

Alimentary pharmacology & therapeutics, 2013-08, Vol.38 (3), p.326-327

2013

Volltextzugriff (PDF)

A rare case series of concomitant inflammatory bowel disease, sporadic adenomas, and serrated polyposis syndrome

Journal of Crohn's and colitis, 2014-12, Vol.8 (12), p.1735-1739

2014

Volltextzugriff (PDF)

Setting priorities for comparative effectiveness research in inflammatory bowel disease: Results of an international provider survey, expert rand panel, and patient focus groups

Inflammatory bowel diseases, 2012-12, Vol.18 (12), p.2294-2300

2012

Volltextzugriff (PDF)

Positive Fluid Balance Is Associated with Higher Mortality and Prolonged Mechanical Ventilation in Pediatric Patients with Acute Lung Injury

Critical Care Research and Practice, 2011-01, Vol.2011 (2011), p.90-94

2011

Volltextzugriff (PDF)

Management of active Crohn disease

JAMA : the journal of the American Medical Association, 2013-05, Vol.309 (20), p.2150

Cheifetz, Adam S

2013

Volltextzugriff (PDF)

Management of Inpatient Inflammatory Bowel Disease: A Comprehensive Handbook

1, 2021

Volltextzugriff (PDF)

Pediatric acute respiratory distress syndrome: consensus recommendations from the Pediatric Acute Lung Injury Consensus Conference

Pediatric critical care medicine, 2015-06, Vol.16 (5), p.428-439

2015

Volltextzugriff (PDF)

Protocolized sedation vs usual care in pediatric patients mechanically ventilated for acute respiratory failure: a randomized clinical trial

JAMA : the journal of the American Medical Association, 2015-01, Vol.313 (4), p.379

2015

Volltextzugriff (PDF)

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

The New England journal of medicine, 2019-06, Vol.380 (24), p.2295-2306

2019

Volltextzugriff (PDF)

Cancer Screening in Inflammatory Bowel Disease: A Guide to Risk Management and Techniques

1st ed. 2019., 2019

Volltextzugriff (PDF)

Urocortin II mediates pro-inflammatory effects in human colonocytes via corticotropin-releasing hormone receptor 2

Gut, 2007-04, Vol.56 (9), p.1210-1217

2007

Volltextzugriff (PDF)

1 – 25 von 1.185

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.006)
Mit Volltextzugriff
(915)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Psoriasis associated with anti‐tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature

The Crohn's disease activity index (CDAI) is similarly elevated in patients with Crohn's disease and in patients with irritable bowel syndrome

Meta‐analysis: targeting the intestinal microbiota in prophylaxis for post‐operative Crohn’s disease

Outcomes after escalation of infliximab therapy in ambulatory patients with moderately active ulcerative colitis

Systematic review: the quality of the scientific evidence and conflicts of interest in international inflammatory bowel disease practice guidelines

Infliximab trough concentrations during maintenance therapy are associated with endoscopic and histologic healing in ulcerative colitis

The use of pharmacological prophylaxis against venous thromboembolism in hospitalised patients with severe active ulcerative colitis

Letter: infliximab concentrations during induction therapy—one size does not fit all

Editorial: early post‐induction anti‐TNF drug monitoring can predict long‐term therapeutic outcomes in inflammatory bowel disease

Editorial: therapeutic de‐escalation of anti‐tumour necrosis factor therapy – is less enough?

The impact of infliximab infusion reactions on long‐term outcomes in patients with Crohn’s disease

Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014

Commentary: irritable bowel syndrome and the CDAI – misleading activity by straw men; authors’ reply

Letter: inflammatory bowel disease guidelines and conflicts of interest – authors' reply

Letter: international IBD practice guidelines – authors’ reply

A rare case series of concomitant inflammatory bowel disease, sporadic adenomas, and serrated polyposis syndrome

Setting priorities for comparative effectiveness research in inflammatory bowel disease: Results of an international provider survey, expert rand panel, and patient focus groups

Positive Fluid Balance Is Associated with Higher Mortality and Prolonged Mechanical Ventilation in Pediatric Patients with Acute Lung Injury

Management of active Crohn disease

Management of Inpatient Inflammatory Bowel Disease: A Comprehensive Handbook

Pediatric acute respiratory distress syndrome: consensus recommendations from the Pediatric Acute Lung Injury Consensus Conference

Protocolized sedation vs usual care in pediatric patients mechanically ventilated for acute respiratory failure: a randomized clinical trial

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

Cancer Screening in Inflammatory Bowel Disease: A Guide to Risk Management and Techniques

Urocortin II mediates pro-inflammatory effects in human colonocytes via corticotropin-releasing hormone receptor 2

Suchergebnisse filtern